TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 17.46

Change

-0.21 (-1.19)%

Market Cap

N/A

Volume

5.70M

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

-1.96 (-1.01%)

USD 88.29B
HLN Haleon plc

-0.15 (-1.40%)

USD 48.57B
TAK Takeda Pharmaceutical Co Ltd A..

+0.04 (+0.28%)

USD 45.08B
RDY Dr. Reddy’s Laboratories Ltd..

-0.36 (-0.45%)

USD 13.46B
CTLT Catalent Inc

+0.22 (+0.37%)

USD 10.91B
ELAN Elanco Animal Health

-0.06 (-0.41%)

USD 7.26B
BHC Bausch Health Companies Inc

-0.11 (-1.33%)

USD 3.00B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.11 (-1.26%)

USD 2.66B
CPHI China Pharma Holdings Inc

+0.03 (+15.25%)

USD 3.66M
YCBD cbdMD Inc

N/A

USD 1.73M

ETFs Containing TEVA

ISRA VanEck Israel ETF 9.78 % 0.60 %

+0.14 (+-0.07%)

USD 0.08B
FLWR:SW 5.80 % 0.00 %

N/A

N/A
ISRPF iShares Public Limited Co.. 5.39 % 0.00 %

N/A

USD 2.22B
ISRZF iShares II Public Limited.. 5.39 % 0.00 %

N/A

N/A
ISRCF iShares V Public Limited .. 4.81 % 0.00 %

N/A

N/A
ISRWF iShares II Public Limited.. 4.75 % 0.00 %

N/A

N/A
ISRHF iShares V Public Limited .. 4.35 % 0.00 %

+0.10 (+-0.07%)

N/A
ISRUF iShares V Public Limited .. 4.35 % 0.00 %

N/A

N/A
IDVO Amplify International Enh.. 3.08 % 0.00 %

-0.02 (-0.07%)

USD 0.10B
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

+0.06 (+-0.07%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GWL 0.00 % 0.34 %

N/A

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 67.24% 94% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.24% 94% A 98% N/A
Trailing 12 Months  
Capital Gain 89.99% 88% B+ 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.99% 88% B+ 96% N/A
Trailing 5 Years  
Capital Gain 150.50% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 150.50% 93% A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 10.45% N/A N/A 69% C-
Dividend Return 10.45% N/A N/A 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.53% N/A N/A 27% F
Risk Adjusted Return 28.62% N/A N/A 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector